Alix Beaupierre on Patient Education for CAR T-cell Therapy Clinical Trials
Alix Beaupierre, RN, BSN, OCN, Moffitt Cancer Center, explains the patient education program created for a recent CAR T-cell therapy clinical trial.
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
2 Clarke Drive Cranbury, NJ 08512